[SLRX] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
02-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -6.49%
YoY- 22.51%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 1,243 165 246 336 113 0 0 -
PBT -1,784 -1,385 -9,052 -8,805 -11,363 -7,078 -2,190 -3.35%
Tax 62 0 0 0 0 0 0 -
NP -1,784 -1,385 -9,052 -8,805 -11,363 -7,078 -2,190 -3.35%
Tax Rate - - - - - - - -
Total Cost 3,028 1,549 9,297 9,140 11,476 7,078 2,190 5.54%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin -143.51 -840.76 -3,687.09 -2,624.15 -10,083.98 0.00 0.00 -
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS -3.20 -11.48 -313.66 -321.24 -440.98 -294.26 -242.22 -51.34%
EPS Diluted -3.20 -11.48 -313.66 -321.24 -440.98 -294.26 -242.22 -51.34%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.